GlassScriptPhysician profile
Mimoza Zaka
NPI 1053786954
$9,693.02
in general payments reported to CMS, 2019-2025
38 companies · $1,789 in 2025
The $1,789 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,404 · 2022: $1,878 · 2023: $2,349 · 2024: $2,273 · 2025: $1,789.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,411.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $1,541.49 | 2021-2024 | Nuplazid |
| Teva Pharmaceuticals USA, INC. | $940.94 | 2021-2025 | Uzedy, Austedo Xr, Ajovy |
| Alexion Pharmaceuticals, INC. | $831.32 | 2021-2024 | Soliris |
| Astrazeneca Pharmaceuticals LP | $655.62 | 2021-2025 | Wainua |
| Novo Nordisk INC | $596.14 | 2022-2025 | Wegovy |
| Neurocrine Biosciences, INC. | $587.78 | 2022-2025 | Ingrezza |
| Otsuka America Pharmaceutical, INC. | $496.78 | 2024-2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $409.27 | 2021-2025 | Spravato |
| Medtronic, INC. | $275.90 | 2024-2025 | Interstim, Symplicity G3 |
| Corium, LLC | $234.31 | 2023 | Adlarity |
| Bayer Healthcare Pharmaceuticals INC. | $189.51 | 2023-2024 | |
| Boston Scientific Corporation | $183.31 | 2021-2024 | Wavewriter Alpha Prime 16 |
| Averitas Pharma INC. | $144.96 | 2025 | Qutenza |
| Inspire Medical Systems, INC. | $141.92 | 2023 | Inspire |
| Silk Road Medical, INC. | $141.60 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $139.15 | 2024 | Impella |
| Gilead Sciences, INC. | $124.99 | 2024 | |
| Agios Pharmaceuticals, INC. | $124.99 | 2025 | Pyrukynd |
| Jazz Pharmaceuticals INC. | $124.74 | 2025 | |
| Amgen INC. | $124.74 | 2023 | Repatha |
| Takeda Pharmaceuticals U.S.A., INC. | $123.75 | 2024 | Hyqvia |
| Lilly USA, LLC | $121.86 | 2024 | Omvoh |
| Glaxosmithkline, LLC. | $121.83 | 2025 | Benlysta |
| Actelion Pharmaceuticals US, INC. | $121.35 | 2024 | Uptravi, Opsumit |
| Lundbeck LLC | $115.00 | 2023 | Vyepti |
| Sk Life Science, INC. | $114.48 | 2022 | |
| Biogen, INC. | $107.69 | 2021 | |
| Viiv Healthcare Company | $107.10 | 2024 | Dovato |
| Axsome Therapeutics, INC. | $102.15 | 2025 | Auvelity |
| Corcept Therapeutics | $100.00 | 2021 | |
| Sun Pharmaceutical Industries INC. | $94.74 | 2025 | |
| Eisai INC. | $93.70 | 2025 | |
| Amarin Pharma, INC. | $90.92 | 2024 | |
| Janssen Biotech, INC. | $87.62 | 2022 | |
| Mayne Pharma Commercial LLC | $80.07 | 2023 | |
| Coloplast Corp | $44.42 | 2025 | |
| Dexcom, INC. | $35.07 | 2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $21.81 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mimoza Zaka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.